Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jan 22;34(6):433–440. doi: 10.1136/acupmed-2015-010934

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

PMC Copyright notice

Measurements of: (A) pulmonary resistance (R_L) over time; (B) eosinophil count (EOS); and (C) serum corticosterone concentrations, in 10 healthy rats (Control group), 17 rats sensitised to ovalbumin after sham adrenalectomy (SADX+OVA group), and 60 adrenalectomised rats sensitised to ovalbumin and treated with manual acupuncture (ADX+OVA+MA group, n=20), subjected to manual restraint without needling (ADX+OVA+MR group, n=20) or left untreated (ADX+OVA group, n=20) before ovalbumin challenge to model asthma. Data are mean±SEM. ∗p<0.05 ADX+OVA versus Control groups. Δp<0.05 ADX+OVA+MA versus ADX+OVA groups. #p<0.05, ADX+OVA+MR versus ADX+OVA groups.